| Ytd | 36.57% | |
| 1y | -11.06% |
| Open | 20.85 | Prev Close | 20.82 | Low | 20.79 | High | 21.59 | Mkt Cap | 1.32B |
| Vol | 836.76K | Avg Vol | 1.38M | EPS | 0.24 | P/E | 89.79 | Forward P/E | 38.75 |
| Beta | 2.03 | Short Ratio | 6.78 | Inst. Own | 87.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 21.80 | 200-d Avg | 17.41 | 1yr Est | 28.42 |
HCA Healthcare (NYSE: HCA - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are b
Omada Health, Inc. (NASDAQ: OMDA - Get Free Report) has been given an average recommendation of "Mod
Bank of America Corp DE acquired a new stake in Omada Health, Inc. (NASDAQ: OMDA) during the undefin
NeoGenomics (NASDAQ: NEO - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are bo
The transaction represented 3% of the insider's direct equity holdings before the filing. The sale w
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises th
Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript
SAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, be
SAN FRANCISCO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, be
Traded 31,457 shares with a transaction value of ~$735,150 based on a weighted average price of $23.
Shares of Omada Health, Inc. (NASDAQ: OMDA - Get Free Report) have been given an average rating of "
BlackRock Inc. bought a new position in shares of Omada Health, Inc. (NASDAQ: OMDA) in the undefined
Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-
JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the
Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperfor
Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and posi
Baird analyst Vikram Kesavabhotla maintains Omada Health (NASDAQ:OMDA) with a Neutral and raises
Omada Health NASDAQ: OMDA highlighted record second-quarter revenue and margin performance at the Ca
BTIG analyst David Larsen maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price ta
Although the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performe
Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript
Omada Health NASDAQ: OMDA reported record second-quarter results for 2026, citing broad-based growth
Omada Health, Inc. (OMDA) came out with quarterly earnings of $0.15 per share, beating the Zacks Con
Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $322.000 million-$330.000 million to $33
Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.08 per share which beat the analyst con
Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Qu
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises th
SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-vi
SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-vi
Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and raise
Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperfor
Wall Street analysts change outlook on top stocks. For detailed ratings, upgrades/downgrades, see an
BTIG analyst David Larsen initiates coverage on Omada Health (NASDAQ:OMDA) with a Buy rating and
Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess
Morgan Stanley analyst Craig Hettenbach reiterates Omada Health (NASDAQ:OMDA) with a Overweight a
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises th
Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperfor
Evercore ISI Group analyst Elizabeth Anderson maintains Omada Health (NASDAQ:OMDA) with a Outperf
Wells Fargo analyst Stan Berenshteyn maintains Omada Health (NASDAQ:OMDA) with a Equal-Weight and